Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4⁺Foxp3⁺ Treg Induction

References

• Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10–18. doi:10.1038/s41590-020-00816-x
   PubMed Web of Science ®Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196. doi:10.1016/j.immuni.2017.02.006
   PubMed Web of Science ®Google Scholar
• Roberti A, Chaffey LE, Greaves DR. NF-kappaB signaling and inflammation-drug repurposing to treat inflammatory disorders? Biology. 2022;11(3):372. doi:10.3390/biology11030372
   PubMed Web of Science ®Google Scholar
• Lespasio MJ, Sultan AA, Piuzzi NS, et al. Hip osteoarthritis: a primer. Perm J. 2018;22:17–84. doi:10.7812/TPP/17-084
   PubMedGoogle Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. doi:10.1038/nrdp.2018.1
   PubMed Web of Science ®Google Scholar
• Chang HD, Tokoyoda K, Radbruch A. Immunological memories of the bone marrow. Immunol Rev. 2018;283(1):86–98. doi:10.1111/imr.12656
   PubMed Web of Science ®Google Scholar
• Feuerer M, Beckhove P, Garbi N, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med. 2003;9(9):1151–1157. doi:10.1038/nm914
   PubMed Web of Science ®Google Scholar
• Nemoto Y, Kanai T, Makita S, et al. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis. Gastroenterology. 2007;132(1):176–189. doi:10.1053/j.gastro.2006.10.035
   PubMed Web of Science ®Google Scholar
• Zou L, Barnett B, Safah H, et al. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 2004;64(22):8451–8455. doi:10.1158/0008-5472.CAN-04-1987
   PubMed Web of Science ®Google Scholar
• Rudnicka W, Burakowski T, Warnawin E, et al. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients. Eur J Immunol. 2009;39(5):1211–1220. doi:10.1002/eji.200838617
   PubMed Web of Science ®Google Scholar
• Kuca-Warnawin E, Burakowski T, Kurowska W, et al. Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15? Ann Rheum Dis. 2011;70(1):227–233. doi:10.1136/ard.2009.124966
   PubMed Web of Science ®Google Scholar
• Kuca-Warnawin E, Kurowska W, Prochorec-Sobieszek M, et al. Rheumatoid arthritis bone marrow environment supports Th17 response. Arthritis Res Ther. 2017;19(1):274. doi:10.1186/s13075-017-1483-x
   PubMed Web of Science ®Google Scholar
• Massalska M, Radzikowska A, Kuca-Warnawin E, et al. CD4(+)FOXP3(+) T cells in rheumatoid arthritis bone marrow are partially impaired. Cells. 2020;9:3. doi:10.3390/cells9030549
   Web of Science ®Google Scholar
• Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225–252. doi:10.1146/annurev.immunol.19.1.225
   PubMed Web of Science ®Google Scholar
• Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood. 2005;105(4):1574–1581. doi:10.1182/blood-2004-06-2089
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281(5380):1191–1193. doi:10.1126/science.281.5380.1191
   PubMed Web of Science ®Google Scholar
• Miwa N, Hayakawa S, Miyazaki S, et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod. 2005;11(12):865–870.
   PubMed Web of Science ®Google Scholar
• Murray MF. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect Dis. 2003;3(10):644–652. doi:10.1016/S1473-3099(03)00773-4
   PubMed Web of Science ®Google Scholar
• Blair HA, Deeks ED. Abatacept: a Review in Rheumatoid Arthritis. Drugs. 2017;77(11):1221–1233. doi:10.1007/s40265-017-0775-4
   PubMed Web of Science ®Google Scholar
• Bozec A, Luo Y, Engdahl C, Figueiredo C, Bang H, Schett G. Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner. Arthritis Res Ther. 2018;20(1):24. doi:10.1186/s13075-018-1527-x
   PubMed Web of Science ®Google Scholar
• Ngwube A, Shah N, Godder K, Jacobsohn D, Hulbert ML, Shenoy S. Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease. Blood Adv. 2020;4(16):3894–3899. doi:10.1182/bloodadvances.2020002236
   PubMed Web of Science ®Google Scholar
• Santopaolo M, Sullivan N, Thomas AC, et al. Activation of bone marrow adaptive immunity in type 2 diabetes: rescue by co-stimulation modulator abatacept. Front Immunol. 2021;12:609406. doi:10.3389/fimmu.2021.609406
   PubMed Web of Science ®Google Scholar
• Ciechomska M, Wojtas B, Bonek K, et al. Comprehensive microRNA and transcriptomic profiling of rheumatoid arthritis monocytes: role of microRNA-146b in pro-inflammatory progression. Rheumatology. 2021;60(11):5424–5435. doi:10.1093/rheumatology/keab407
   PubMed Web of Science ®Google Scholar
• Bahraoui E, Serrero M, Planes R. HIV-1 Tat - TLR4/MD2 interaction drives the expression of IDO-1 in monocytes derived dendritic cells through NF-kappaB dependent pathway. Sci Rep. 2020;10(1):8177. doi:10.1038/s41598-020-64847-y
   PubMed Web of Science ®Google Scholar
• Hettinger J, Richards DM, Hansson J, et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol. 2013;14(8):821–830. doi:10.1038/ni.2638
   PubMed Web of Science ®Google Scholar
• Hardin JA. Dendritic cells: potential triggers of autoimmunity and targets for therapy. Ann Rheum Dis. 2005;64(Suppl 4):iv86–90. doi:10.1136/ard.2005.044560
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/art.1780310302
   PubMed Web of Science ®Google Scholar
• Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the Hip. Arthritis Rheum. 1991;34(5):505–514. doi:10.1002/art.1780340502
   PubMed Web of Science ®Google Scholar
• Kontny E, Szczepanska K, Kowalczewski J, et al. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 2000;43(10):2169–2177.
   PubMed Web of Science ®Google Scholar
• Razmara M, Hilliard B, Ziarani AK, Chen YH, Tykocinski ML. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells. Int Immunol. 2008;20(4):471–483.
   PubMed Web of Science ®Google Scholar
• Holmes EW. Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Anal Biochem. 1988;172(2):518–525. doi:10.1016/0003-2697(88)90478-2
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Kurowska W, Przygodzka M, Jakubaszek M, Kwiatkowska B, Maslinski W. Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development. J Clin Med. 2020;9(5):1555. doi:10.3390/jcm9051555
   PubMed Web of Science ®Google Scholar
• Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. 2002;196(4):447–457. doi:10.1084/jem.20020052
   PubMed Web of Science ®Google Scholar
• Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002;196(4):459–468. doi:10.1084/jem.20020121
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Nakahama T, Le DH, Van Son L, Chu HH, Kishimoto T. Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol. 2014;5:551. doi:10.3389/fimmu.2014.00551
   PubMed Web of Science ®Google Scholar
• Merlo LMF, DuHadaway JB, Montgomery JD, et al. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses. Front Immunol. 2020;11:1861. doi:10.3389/fimmu.2020.01861
   PubMed Web of Science ®Google Scholar
• Ball HJ, Sanchez-Perez A, Weiser S, et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene. 2007;396(1):203–213. doi:10.1016/j.gene.2007.04.010
   PubMed Web of Science ®Google Scholar
• Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 2003;9(10):1269–1274. doi:10.1038/nm934
   PubMed Web of Science ®Google Scholar
• Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res. 2006;12(4):1144–1151. doi:10.1158/1078-0432.CCR-05-1966
   PubMed Web of Science ®Google Scholar
• Mondal A, Smith C, DuHadaway JB, et al. IDO1 is an Integral Mediator of Inflammatory Neovascularization. EBioMedicine. 2016;14:74–82. doi:10.1016/j.ebiom.2016.11.013
   PubMed Web of Science ®Google Scholar
• Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology. 2003;125(6):1762–1773. doi:10.1053/j.gastro.2003.08.031
   PubMed Web of Science ®Google Scholar
• Sakurai K, Zou JP, Tschetter JR, Ward JM, Shearer GM. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002;129(1–2):186–196. doi:10.1016/s0165-5728(02)00176-5
   PubMed Web of Science ®Google Scholar
• Szanto S, Koreny T, Mikecz K, Glant TT, Szekanecz Z, Varga J. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice. Arthritis Res Ther. 2007;9(3):R50. doi:10.1186/ar2205
   PubMed Web of Science ®Google Scholar
• Davison LM, Liu JC, Huang L, Carroll TM, Mellor AL, Jorgensen TN. Limited effect of Indolamine 2,3-Dioxygenase expression and enzymatic activity on lupus-like disease in B6.Nba2 mice. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.02017
   Web of Science ®Google Scholar
• Ogbechi J, Clanchy FI, Huang YS, Topping LM, Stone TW, Williams RO. IDO activation, inflammation and musculoskeletal disease. Exp Gerontol. 2020;131:110820. doi:10.1016/j.exger.2019.110820
   PubMed Web of Science ®Google Scholar
• Yasui H, Takai K, Yoshida R, Hayaishi O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci U S A. 1986;83(17):6622–6626.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liang X, Yin X, et al. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-gamma-induced immunologic dormancy of tumor-repopulating cells. Nat Commun. 2017;8:15207. doi:10.1038/ncomms15207
   PubMed Web of Science ®Google Scholar
• Simms PE, Ellis TM. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol. 1996;3(3):301–304. doi:10.1128/cdli.3.3.301-304.1996
   PubMedGoogle Scholar
• Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest. 2007;117(5):1147–1154. doi:10.1172/JCI31178
   PubMed Web of Science ®Google Scholar
• Wakamatsu E, Omori H, Kawano A, Ogawa S, Abe R. Strong TCR stimulation promotes the stabilization of Foxp3 expression in regulatory T cells induced in vitro through increasing the demethylation of Foxp3 CNS2. Biochem Biophys Res Commun. 2018;503(4):2597–2602. doi:10.1016/j.bbrc.2018.07.021
   PubMed Web of Science ®Google Scholar
• Tarbell KV, Yamazaki S, Steinman RM. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol. 2006;18(2):93–102. doi:10.1016/j.smim.2006.01.009
   PubMed Web of Science ®Google Scholar
• Alvarez-Quiroga C, Abud-Mendoza C, Doniz-Padilla L, et al. CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis. J Clin Immunol. 2011;31(4):588–595. doi:10.1007/s10875-011-9527-5
   PubMed Web of Science ®Google Scholar
• Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol. 2005;6(2):152–162. doi:10.1038/ni1160
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M, Fuchs D. Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol. 2006;25(3):334–337. doi:10.1007/s10067-005-0056-6
   PubMed Web of Science ®Google Scholar
• Ozkan Y, Mete G, Sepici-Dincel A, Sepici V, Simsek B. Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients. Clin Rheumatol. 2012;31(1):29–34. doi:10.1007/s10067-011-1767-5
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Hwang KW, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4(12):1206–1212. doi:10.1038/ni1003
   PubMed Web of Science ®Google Scholar